Article
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohorts.
International journal of cancer - 1 Feb 2024
Osterlund Emerik, Ristimäki Ari, Mäkinen Markus J, Kytölä Soili, Kononen Juha, Pfeiffer Per, Soveri Leena-Maija, Keinänen Mauri, Sorbye Halfdan, Nunes Luís, Salminen Tapio, Nieminen Lasse, Uutela Aki, Halonen Päivi, Ålgars Annika, Sundström Jari, Kallio Raija, Ristamäki Raija, Lamminmäki Annamarja, Stedt Hanna, Heervä Eetu, Kuopio Teijo, Sjöblom Tobias, Isoniemi Helena, Glimelius Bengt, Osterlund Pia
Abstract excerpt
BRAF-V600E mutation (mt) is a strong negative prognostic and predictive biomarker in metastatic colorectal cancer (mCRC). Non-V600Emt, designated atypical BRAFmt (aBRAFmt) are rare, and little is known about their frequency, co-mutations and prognostic and predictive role. These were compared between mutational groups of mCRC patients collected from three Nordic population-based or real-world cohorts. Pathology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
